IEX

IDEX Corporation 2008 Annual Report (10-K) Summary

Business Context and Reporting Period

Company: IDEX Corporation (IDEX)
Reporting Period: Fiscal Year Ended December 31, 2008
Business Overview: IDEX is an applied solutions company specializing in fluid and metering technologies, health and science technologies, dispensing equipment, and fire, safety, and diversified products. The company operates through four reportable segments: Fluid & Metering Technologies, Health & Science Technologies, Dispensing Equipment, and Fire & Safety/Diversified Products. The company pursues growth through organic development and strategic acquisitions.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Sales increased 10% to $1.49 billion. This was driven primarily by acquisitions (contributing 9% growth) and foreign currency translation (1%), while organic sales were flat.
• Profitability Decline: Operating income decreased 17% to $212.4 million. This decline was primarily due to a $30.1 million goodwill impairment charge and $18.0 million in restructuring expenses.
• Segment Performance:
  • Fluid & Metering Technologies: Sales up 22% (driven by acquisitions and 4% organic growth); Operating income up 7%.
  • Dispensing Equipment: Sales down 8% (organic sales down 13%); Operating loss of $10.6 million due to market deterioration and the goodwill impairment charge.
  • Fire & Safety/Diversified Products: Sales up 4%; Operating income up 11%.
• Acquisitions: Significant 2008 acquisitions included ADS ($156.4M), Richter ($102.1M), iPEK ($44.7M), IETG ($37.4M), and Semrock ($61.1M).
• Debt Levels: Total borrowings increased by approximately $99 million to $554 million, largely to finance acquisitions.

Guidance, Outlook, Risks, and Unusual Items

• Unusual Items:
  • Goodwill Impairment: Recorded a $30.1 million non-cash charge for the Fluid Management Americas reporting unit within the Dispensing Equipment segment due to a downturn in capital spending and loss of market share.
  • Restructuring: Incurred $18.0 million in pre-tax restructuring expenses related to workforce reductions and the closure of a manufacturing facility in Milan, Italy.
• Risks:
  • Economic Conditions: The global financial crisis and economic uncertainty pose risks to customer demand, credit availability, and supplier solvency.
  • Foreign Currency: 47% of sales are international; significant fluctuations in the Euro, British Pound, and other currencies could impact results.
  • Intangible Assets: Goodwill and intangible assets total $1.47 billion. Further declines in fair value could trigger additional impairment charges.
  • Interest Rates: The company has $204 million in floating-rate debt exposed to interest rate movements.
• Liquidity: Management believes current liquidity is sufficient to meet operating requirements, debt repayments, and dividends for the next 12 months. The company maintains a $600 million credit facility with approximately $145 million available.
• Share Repurchases: The Board authorized a $125 million share repurchase program; $50 million was utilized in 2008.

Investor Verification Checklist

• Goodwill Impairment Risk: Verify the stability of the Dispensing Equipment segment and the potential for further impairment charges given the $204.2 million goodwill balance in two reporting units that are sensitive to a 10% decrease in fair value.
• Acquisition Integration: Assess the integration progress and accretive performance of the seven major acquisitions completed in 2008 (ADS, Richter, iPEK, IETG, Semrock, etc.).
• Debt Covenants: Confirm continued compliance with financial covenants (minimum interest coverage ratio of 3.0 to 1 and maximum leverage ratio of 3.25 to 1) amidst economic volatility.
• Organic Growth: Monitor organic sales trends, which were flat in 2008, to determine if the company can grow without relying solely on M&A.
• Foreign Exposure: Evaluate the impact of currency fluctuations on the 47% of revenue generated outside the U.S.